Virginie Laguitton

Hôpital de la Timone

Papers

1

Total Citations

18

H-Index

1

About

Dr. Virginie Laguitton is a leading clinical researcher in the field of neuromodulation for drug-resistant epilepsy, with a specific focus on deep brain stimulation (DBS) of the medial pulvinar nucleus (PuM). Her major contribution is pioneering the investigation of this novel thalamic target for patients with focal epilepsy who have not responded to medication or vagal nerve stimulation. As the lead author of the interim 12-month results from the landmark PULSE study (2024, 18 citations), Dr. Laguitton provided critical early evidence that PuM-DBS can significantly reduce seizure frequency while also addressing debilitating comorbidities. This work is notable for its potential to expand therapeutic options for a patient population with limited alternatives. Her research is characterized by rigorous prospective trial design and a patient-centered focus on both seizure control and quality of life. With a growing citation impact, Dr. Laguitton is establishing herself as a key voice in advancing surgical treatments for refractory epilepsy, offering new hope through targeted brain stimulation.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Medial pulvinar stimulation for focal drug-resistant epilepsy: interim 12-month results of the PULSE study
18 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Hôpital de la Timone

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago